IP Library › Assignment 054666/0617
Patent Assignment
Reel/Frame 054666/0617

Assignment of Assignor's Interest

Recorded: 2020-12-16 Pages: 7
Assignors
VISNICK, MELEAN
Executed: 2019-06-26
JIANG, XIN
Executed: 2019-06-26
Assignee
REATA PHARMACEUTICALS, INC.
2801 GATEWAY DRIVE, SUITE 150, IRVING, TEXAS, 75063
Covered Property (1)
Cysteine-Dependent Inverse Agonists of Nuclear Receptors Ror-Gamma/Ror-Gamma-T and Methods of Treating Diseases or Disorders Therewith
Application: 17/252,841 →
Publication: US 2021/0147380
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Patent Security Agreement May 18, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063697/0461 →
Amended and Restated Patent Security Agreement Jul 12, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064264/0557 →
Release of Security Interest Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0130 →
Release of Security Interest Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0228 →